Feedback / Questions
armesocarb (MLR-1019) - Melior, Adhera Therap
https://www.globenewswire.com/news-release/2021/10/15/2315095/0/en/Manufacturing-Commences-on-Adhera-s-MLR-1019-for-Phase-2a-Clinical-Trial-Treating-Parkinson-s-Disease.html
Oct 15, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next